Optimal Lidocaine Buffering to Reduce Injection Pain in Local Anesthesia

ClinicalTrials.gov ID: NCT02647892

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02647892. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 10:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the optimal amount of lidocaine buffering needed to decrease injection pain when administering local anesthesia.

Study identification

NCT ID: NCT02647892
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 4
Lead sponsor: University of Nebraska; Other
Enrollment: 70 participants

Conditions and interventions

Conditions

Local Anesthesia

Interventions

lidocaine Drug
sodium bicarbonate Drug

Drug

Eligibility (public fields only)

Age range: 19 Years to 100 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 8, 2016 (Actual)
Primary completion: Nov 5, 2021 (Actual)
Completion: Nov 5, 2021 (Actual)
Last update posted: Aug 21, 2023

2016 – 2021

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
University of Nebraska Medical Center	Omaha	Nebraska	68198	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02647892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 21, 2023 · Synced Nov 12, 2026